ATMU vs BABA

The company exhibits weak financial health with a Piotroski F-Score of 3/9, indicating significant concerns in profitability, leverage, and operating efficiency. Despite this, Atmus shows strong profitability metrics including an ROE of 71.52% and solid revenue and earnings growth, supported by a bullish analyst recommendation and consistent earnings beats. Valuation is rich relative to Graham’s defensive standard ($14.97 vs. current price of $56.55), but growth expectations justify a premium. However, bearish insider activity and high leverage temper optimism, creating a mixed outlook.

The Advanced Deterministic Scorecard reveals a mixed financial profile for Alibaba (BABA), with a weak Piotroski F-Score of 4/9 indicating suboptimal financial health, and no available Altman Z-Score limiting distress risk assessment. While valuation metrics appear favorable relative to peers—especially a Price/Sales of 0.41 and Forward P/E of 19.50—earnings growth is sharply negative (YoY EPS down 71%), and recent quarterly beats have reversed into consistent misses over the last four quarters. Strong insider sentiment and a bullish analyst consensus (strong_buy) contrast with deteriorating profitability and weak technical trends (10/100). The stock trades significantly above the Graham Number ($102.68) and intrinsic value estimate ($51.38), suggesting overvaluation unless growth rebounds materially.